Skip to main content

Peer Review reports

From: A randomized phase II trial of MR-guided prostate stereotactic body radiotherapy administered in 5 or 2 fractions for localized prostate cancer (FORT)

Original Submission
9 Jun 2023 Submitted Original manuscript
10 Jul 2023 Reviewed Reviewer Report
28 Jul 2023 Reviewed Reviewer Report
2 Aug 2023 Reviewed Reviewer Report
22 Aug 2023 Author responded Author comments - Himanshu Nagar
Resubmission - Version 2
22 Aug 2023 Submitted Manuscript version 2
29 Aug 2023 Author responded Author comments - Himanshu Nagar
Resubmission - Version 3
29 Aug 2023 Submitted Manuscript version 3
4 Sep 2023 Author responded Author comments - Himanshu Nagar
Resubmission - Version 4
4 Sep 2023 Submitted Manuscript version 4
10 Sep 2023 Reviewed Reviewer Report
20 Sep 2023 Reviewed Reviewer Report
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
21 Sep 2023 Editorially accepted
30 Sep 2023 Article published 10.1186/s12885-023-11430-z

You can find further information about peer review here.

Back to article page